Clorox reported Q3 fiscal year 2022 results with a net sales increase of 2% to $1.8 billion. Diluted EPS increased significantly due to a noncash impairment in the Vitamins, Minerals and Supplements business during the year-ago period, while adjusted EPS decreased due to lower gross margin. The company updated its outlook to reflect higher than previously anticipated commodity and manufacturing and logistics costs.
Net sales increased 2% to $1.8 billion, with organic sales also growing 2%.
Diluted EPS increased 347% to $1.21, while adjusted EPS decreased 19% to $1.31.
Gross margin decreased to 35.9% due to higher manufacturing, logistics, and commodity costs.
The company updated its fiscal year 2022 outlook, expecting net sales to decrease 1% to 4% and adjusted EPS to be between $4.05 and $4.30.
Clorox updated its outlook for fiscal year 2022, expecting net sales to decrease 1% to 4% and adjusted EPS to be between $4.05 and $4.30, reflecting higher commodity and manufacturing and logistics costs.
Visualization of income flow from segment revenue to net income